Your session is about to expire
← Back to Search
Glufosfamide vs Fluorouracil for Pancreatic Cancer
Study Summary
This trial is testing whether a different chemotherapy drug may help people with pancreatic cancer who have already tried and failed one gemcitabine-based chemotherapy regimen.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2008 Phase 2 trial • 22 Patients • NCT00441467Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are people with the required medical conditions still able to join this clinical trial?
"According to the information available on clinicaltrials.gov, this study is still looking for participants. This trial was first advertised on April 1st, 2014 and received its most recent update on May 6th, 2021."
What medical conditions typically respond best to Glufosfamide treatment?
"Glufosfamide can be used to target actinic keratosis, superficial basal cell carcinoma, rectal carcinoma, and malignant neoplasm of colon."
Is this clinical trial widely available in the United States?
"You may want to consider enrolling in this clinical trial as it is currently recruiting patients from 19 different sites, which are based in locations including Arlington, Riverside and Louisville. To reduce travel-related stress, try to select the location closest to you."
Are there any life-threatening risks associated with Glufosfamide?
"There is both efficacy and safety data available from Phase 3 trials, so Glufosfamide was given a score of 3 for safety."
Are there other published papers on Glufosfamide's efficacy?
"As of right now, there are a total of 331 trials for Glufosfamide that are still recruiting patients. 106 of these studies have reached Phase 3. Additionally, while several clinical trials for Glufosfamide are based in Woolloongabba, Queensland, there are actually 18810 locations running trials related to this medication."
How many people are allowed to participate in this clinical trial at one time?
"That is correct. The clinical trial, which was initially posted on 4/1/2014 and updated on 5/6/2021, is recruiting 480 patients from 19 different locations."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger